Phil Leonard

Phil Leonard is a seasoned executive with extensive experience in the pharmaceutical industry, specializing in commercialization, strategic marketing, and operations. Currently serving as Vice President and Neurodevelopment Franchise Head at Takeda, Leonard oversees a significant $3B P&L for a two-product portfolio, including Vyvanse. Previous roles include Vice President of New Product Launches and Business Insights, where Leonard successfully launched innovative gastroenterology therapies, and Vice President of Commercialization at BioElectron Technology Corporation. With a strong track record of commercial transformation and operational excellence, Leonard has held leadership positions across major pharmaceutical companies, including Amgen and Mallinckrodt Pharmaceuticals, where Phil advanced market access and profitability strategies. Leonard holds an Executive Program in Leadership from Kellogg School of Management, a JD from the University of Iowa College of Law, an MBA in Strategy & Marketing, and a BA in Biology from the University of Iowa.